Rather than increasing medication on a fixed schedule, Nooms physician-designed protocol adjusts dosing based on each patients individual progress and response
Take a look at the full report here: GLP-1 is part of everyday life for around 1.6 million people across the UK, and that number is steadily growing
View at PubMed Gobburu JVS, Agers H, Jusko WJ, Ynddal L
Direct glutathione supplementation: An RCT in India randomized 206 people with type 2 diabetes (aged 31-78, HbA1c 7.1-9.7%) to receive either 500 mg glutathione daily alongside antidiabetic medications for 6 months, or antidiabetic medications alone
Results GLP-1RA reduced major cardiovascular events (MACE) by 14% (HR = 0.86, 95% CI 0.790.94, P = 0.006) with a non-significant heterogeneity between subgroups of patients with and without cardiovascular disease (P = 0.127)